Oxcarbazepine
Product Images NDC 27241-306

This is a description of a medication called Oxcarbazepine Extended-Release Tablets. It is advised to swallow the tablets whole without cutting, crushing, or chewing them. The pharmacist should provide each patient with the accompanying Medication Guide. It is recommended to refer to the package insert for dosage and prescribing information. The package is child-resistant and should be kept out of reach of children. The tablets should be stored at a temperature of 25°C (77°F) with excursions between 15°C to 30°C (59°F to 86°F) and should be protected from light and moisture. They should be dispensed in a tight, light-resistant container. The medication is marketed by Ajanta Pharma USA Inc. and was made in Canada.*

This is a description for Oxcarbazepine Extended-Release Tablets, a medication that should be swallowed whole and not cut, crushed, or chewed. Pharmacists are advised to dispense the accompanying Medication Guide to each patient. The tablets are child-resistant and should be stored at 25°C (77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). It is important to protect the medication from light and moisture by dispensing it in a tight, light-resistant container. The tablets are marketed by Ajanta Pharma USA Inc. and made in Canada. More information on dosage and prescribing can be found in the package insert.*

This text appears to be a medication label for Oxcarbazepine extended-release tablets. It provides storage instructions, dosage guidelines, cautions about child-resistant packaging, and the importance of dispensing the accompanying medication guide to each patient. The tablets are to be stored at controlled room temperature, protected from light and moisture, and dispensed in a tight, light-resistant container. Swallowing the tablets whole is recommended, and they should not be cut, crushed, or chewed. The manufacturer is Ajanta Pharma USA Inc. in Bridgewater, NJ.*